Andere Kunden interessierten sich auch für
![Kinase Drug Discovery]( "Kinase Drug Discovery")
Kinase Drug Discovery250,99 €![Photoreceptor Cell Biology and Inherited Retinal Degenerations]( "Photoreceptor Cell Biology and Inherited Retinal Degenerations")
Photoreceptor Cell Biology and Inherited Retinal Degenerations249,99 €![Active Site-Directed Enzyme Inhibitors]( "Active Site-Directed Enzyme Inhibitors")
Active Site-Directed Enzyme Inhibitors189,99 €![Quadruplex Nucleic Acids]( "Quadruplex Nucleic Acids")
Quadruplex Nucleic Acids202,99 €![Acute Brain Impairment]( "Acute Brain Impairment")
Acute Brain Impairment222,99 €![CPP, Cell-Penetrating Peptides]( "CPP, Cell-Penetrating Peptides")
CPP, Cell-Penetrating Peptides132,99 €![Cpp, Cell-Penetrating Peptides]( "Cpp, Cell-Penetrating Peptides")
Cpp, Cell-Penetrating Peptides159,99 €
Sight loss and blindness is a very prevalent cause of disability. Retinal diseases leading to visual loss affect many people worldwide and the search for adequate drugs remains a challenge and an important area of interest in the drug discovery field. This book addresses approaches to the treatment of retinal diseases, targeting common processes and components. Despite their causative origins, which comprise genetic dystrophies, age-related degenerations, as well as pathologies associated with other diseases, a neurodegenerative component appears, sooner or later, in the course of the disease. As is the case for most neurodegenerative diseases, the available treatments are far from satisfactory. The aim of this book is to highlight research and drug development efforts in targeting such common processes as a potential path to provide treatments to the millions of affected people.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.